PennyStocks101

Can SNCA Manage To Break Above Previous Resistance

NASDAQ:SNCA   None
Great news and all but can SNCA pull from a technical perspective?

"The patent is for the “Transplantation of human neural cells for treatment of neurodegenerative conditions.” Could this be the next step in developing its NSI-566 treatment? Why I say this is because the treatment is specifically designed around neural stem cells. This is developing as things just began to unfold later in the afternoon. However, it could become one of the penny stocks to watch this month."

Source: Are Penny Stocks Profitable? 4 Names To Know Now

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.